Vascular Disrupting Agent Arsenic Trioxide Enhances Thermoradiotherapy of Solid Tumors
Our previous studies demonstrated arsenic trioxide- (ATO-) induced selective tumor vascular disruption and augmentation of thermal or radiotherapy effect against solid tumors. These results suggested that a trimodality approach of radiation, ATO, and local hyperthermia may have potent therapeutic ef...
Main Authors: | Griffin, Robert J., Williams, Brent W., Koonce, Nathan A., Bischof, John C., Song, Chang W., Asur, Rajalakshmi, Upreti, Meenakshi |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261488/ |
Similar Items
-
Acidification-induced sensitization to thermoradiotherapy in breast cancer
by: Leeper, DB, et al.
Published: (2001) -
Comparison of Optical and Power Doppler Ultrasound Imaging for Non-Invasive Evaluation of Arsenic Trioxide as a Vascular Disrupting Agent in Tumors
by: Alhasan, Mustafa K., et al.
Published: (2012) -
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
by: Varghese, Mathews V., et al.
Published: (2013) -
Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
by: Mathews, Vikram, et al.
Published: (2011) -
Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
by: Banerjee, Pathikrit, et al.
Published: (2011)